Research indicates that recurrent mutant genes in pancreatic cancer are predominantly enriched in signaling pathways such as KRAS, TGF‐β, WNT, and NOTCH, which is consistent with our findings [37]. Here, KRAS is linked to pancreatic neoplasm.